11 – 15 July, 2026 – Vancouver, Canada

The 10th World Congress of Biomechanics is coming to vibrant Vancouver from July 11-15, 2026—and we can’t wait to welcome you. We are thrilled to bring you an unforgettable event that celebrates all that’s new, bold, and boundary-pushing in biomechanics. The 10th World Congress of Biomechanics will feature a rich scientific and social program bringing together our global research community. We are honored to announce that the 10th World Congress will serve as the 2026 meeting of our 3 principal partners: the American Society of Biomechanics (ASB), the Canadian Society of Biomechanics/Société Canadienne de Biomécanique (CSB/SCB), and the European Society of Biomechanics (ESB).  

In addition to the high quality and diverse spectrum of scientific tracks you have come to expect from the World Congress, we are striving to amplify contributions of researchers that are embracing emerging areas that we will announce more on as the planning progresses, but will undoubtedly include wearable sensors, artificial intelligence, regenerative medicine, novel devices, and much more. This Congress will be an immersive, hands-on experience in one of the most dynamic cities in the world. Expect workshops that spark creativity, discussions that challenge the status quo, and networking opportunities against the stunning backdrop of Vancouver’s mountains and ocean. 

Join us in continuing the tradition of excellence of more than two decades of World Congresses now past, and forging the next directions in your field. This is more than a Congress; it’s a chance to inspire, be inspired, and chart new directions. Vancouver is calling, and you won’t want to miss this incredible opportunity! 

WCB 2026 Host Societies

ASB is dedicated to advancing the field of biomechanics through research, education, and collaboration. Founded in 1977, ASB serves as a leading platform for scientists, engineers, clinicians, and industry professionals working in areas such as human movement, musculoskeletal mechanics, rehabilitation, sports science, and biomedical engineering. The society also supports student development, mentorship programs, and awards that recognize outstanding contributions to the field.

Canadian Society Of Biomechanics –
Société Canadienne De Biomécanique (CSB/SCB)

Established in 1973, the CSB/SCB is a multidisciplinary organization that promotes the study and application of biomechanics in Canada. With over 250 members worldwide, the society aims to enhance interdisciplinary communication among professionals such as therapists, physicians, engineers, physicists, mathematicians, biologists, sport researchers, and ergonomists. By fostering collaboration across these diverse fields, the CSB/SCB seeks to improve the quality of biomechanics research and its practical applications. CSB/SCB plays a pivotal role in advancing biomechanics research and facilitating the exchange of knowledge among professionals from diverse disciplines.

More info can be found here

17th World Congress on Computational Mechanics

10th European Congress on Computational Methods in Applied Sciences and Engineering

19-24 July 2026 – Munich, Germany

WCCM-ECCOMAS 2026 is expected to be one of the largest congresses in the field of computational mechanics and computational methods in applied sciences and engineering. It is anticipated to attract a diverse and global audience from academia, government, and industry, encompassing all areas of engineering and science. Computational mechanics has become a cornerstone of modern scientific inquiry, driving solutions to some of the most advanced and complex challenges in engineering and beyond.

Special Technology Sessions (STS)

On initiative of the ECCOMAS Industry Interest Group, the WCCM-ECCOMAS Congress 2026 will have Special Technology Sessions (STS) on technologies and research especially of relevance for industrial applications. The STS will address advanced computational methods and tools needed for sustainable aviation, surface transport and other industry areas, as well as their validation and application. At the ECCOMAS Congresses since 1996, the industrial technology oriented STS have a long tradition, based on the fact, that the industry in Europe, especially in Aviation and Transport, had and still has a strong need for advanced computational methods in areas as fluid dynamics, structure mechanics, design optimisation and operations. With artificial intelligence (AI), machine learning and big data handling the challenges get another dimension for industry that needs to be addressed.

The STS will address advanced sustainable technologies for aviation, transport and related industry areas

Aviation, Surface Transport and related industries need to reduce their emissions and to play a driving role towards limiting global warming. Aviation and surface transport have the goal of climate neutrality by mid-century, which requires a significant increase in novel technologies and enhanced innovation.

At WCCM-ECCOMAS 2026, the STS will address the development and use of computational methods, their validation and application, all contributing to reducing emissions of aviation, surface transport and related industries. This includes innovative computational methods and design tools for all relevant technology areas reaching up to concepts of novel configurations and advanced propulsion systems.

As the WCCM-ECCOMAS Congress focuses on computational methods, the aim of the STS and their papers is to present novel computational and digitalized methods and tools (modelling, simulation, optimisation and control, artificial intelligence (AI), etc.) for the application in aviation, surface transport and related industries. The STS can also include the validation and technology demonstration by experiments and testing. In the view of high-performance computing and big data handling, the STS will also address the use of computational methods for innovative production and operation methods for the different transport means.

Lead Institution: University of Cyprus (UCY)
Researchers: G. Vafakos & E. Karvelas
Type: Simulation Study & Video Visualization

Overview

Computational Fluid Dynamics (CFD) simulations have been developed to predict the gas dynamics of the IgnitePLASMA helium plasma jet operating in atmospheric air. This modelling work provides crucial insights into device behavior under different operational parameters, enabling optimization of the plasma-based surgical platform before clinical application.

Key Findings

The simulations investigated two distinct operational modes of the plasma jet:

Laminar Mode:

• Occurs when the jet’s Reynolds number is below a critical threshold (lower flow rates)
• Produces smooth, consistent fluid motion
• Results in predictable jet behavior over time
• Characterized by slower fluid velocity

Turbulent Mode:

• Emerges when flow rate exceeds the threshold
• Creates faster, more stochastic fluid motion
• Exhibits less predictable temporal behavior
• Shows greater variability in flow patterns

May 31 – June 5, 2026

Location: Gifu, Japan

Plasma Medicine has come a long way since the first International Conference on Plasma Medicine was held in 2007. Many devices are commercially available, have regulatory approval for use in humans and are undergoing clinical trials for multiple disease indications. There are ongoing advances in both, fundamental and translational research. The International Society on Plasma Medicine holds biannual conferences to share recent advances in plasma medicine. The conference welcomes scientific contributions from engineers, physicists, chemists, biologists, microbiologists, immunologists, oncologists, clinicians, agriculture scientists among others.

In 2026, the 11th International Conference on Plasma Medicine is being held in the beautiful city of Gifu in Japan, to honor Prof. Masaru Hori, a highly respected leader in the field. After very positive feedback from the community, the conference is again being held jointly with the 10th International Workshop on Plasmas for Cancer Treatment. This is a great opportunity to interact personally with scientists at all levels and affiliations, including students and professors, professionally and socially, across the range of scientific topics that encompass this interdisciplinary field.

The members of the Board of Directors of the International Society on Plasma Medicine and the International Workshop on Plasmas for Cancer Treatment, along with the local hosts hope you will join us to share your work and hear from your colleagues.

More information can be found here

9 – 10 June 2026

Location: Excel London

The London Biotech Show 2026 is Europe’s leading platform for the biotechnology industry, showcasing the full spectrum of red biotech including biopharmaceuticals, therapeutics, gene and cell therapy, regenerative medicine, diagnostics, precision medicine, vaccines, clinical trials, and biomanufacturing.

The event will bring together biotech companies, pharmaceutical leaders, medtech innovators, investors, researchers, policymakers, and solution providers from across the globe to exchange knowledge, forge partnerships, and accelerate innovation.

Through its world-class exhibition, high-level conference, and the Global Biotech Awards, the show enables attendees to explore cutting-edge technologies, secure investments, expand into new markets, and drive the next wave of breakthroughs in healthcare and life sciences.

The event offers a unique platform for key stakeholders to connect and engage across the entire red biotech value chain.

Featuring a comprehensive conference agenda, the event will host a broad spectrum of top-notch speaker keynotes & panel discussions focusing on the latest developments in the red biotechnology vertical. The conference will provide an apt platform for global thought leaders, decision-makers and industry pioneers to share deep industry insights, exchange key ideas.

The show will spotlight cutting-edge innovations across healthcare, research, and life sciences, showcasing the future of biotech on a global stage.

The exhibition at #LBS26 offers a premier platform for leading biotech players and emerging ventures to showcase cutting-edge innovations shaping healthcare, life sciences, and beyond, connecting directly with an international community of stakeholders.

More information about the event can be found here

Kerkrade, The Netherlands

The FLTPD workshop is organized by Eindhoven University of Technology. It will be held in an old abbey Rolduc in Kerkrade, in the south of The Netherlands.
It will take place from the 12th to the 16th of April 2026.

FLTPD workshop brings together scientists working on low-temperature plasmas to present their recent results, focusing on original diagnostic techniques. The workshop is limited to approximately 80 participants from academic, research and industrial institutions. The program consists of expert presentations from around 10 invited speakers, topical talks selected by the International Scientific Committee from submitted abstracts, and poster contributions. All participants will stay at the conference site and are expected to present a contribution.
This is an important and fruitful opportunity for young plasma scientists to share and discuss the latest developments in plasma diagnostics with the experts in the field.

JULY 20TH/25TH – AIX EN PROVENCE, FRANCE

As part of the Ignite Plasma representation at the International Conference on Phenomena in Ionized Gases, ICPIG 2025, Konstantinos Giotis presented our latest progress on  our innovative platform development.

Konstantinos  is a valuable team member of our consortium partner ECE, University of Patras and, after of more than a year’s hard work, the team is proud to showcase their achievements.

Poster ICPIG 2025

More information can be found  here 

Jun 17 – 20 2025  Barcelona, Spain

Ignite Plasma participated in the Plaster Cost Action meeting in June 2025, where our consortium partner Sorbonne University represented our research in cold atmospheric plasma therapy.

Emerick Biaffeu, a team member from Sorbonne University’s Laboratory of Plasma Physics in France, presented his team’s research on behalf of Ignite Plasma, focusing on the therapeutic potential of cold atmospheric plasma (CAP) for treating challenging cancer types.

Research Focus

The presentation outlined CAP as a promising therapeutic approach for patients suffering from cholangiocarcinoma (CCA – cancer of the biliary tract) and pancreatic ductal adenocarcinoma (PDAC) inducing selective cytotoxic effects. These effects can be mediated by different properties of CAP, e.g. reactive oxygen and nitrogen species (RONS) and electric field.

 The research has shown CAP’s anti tumor efficacy through tumor growth regression in murine models carrying subcutaneous tumors. However, the team recognizes that in patient situations, epithelial tissue may influence the penetration of plasma-generated species, potentially reducing treatment efficacy.

More information can be found here

Jun 17 – 20 2025  Barcelona, Spain

The Final Meeting of COST Action PlasTHER, which will also mark the final meeting of our action, will take place in Barcelona from the 17th to 20th June 2025.

The main aim of this COST Action has been to exploit the unprecedented possibilities of atmospheric pressure plasmas in medicine to share, develop and consolidate suitable therapies currently under investigation to make Europe’s science and healthcare world leaders in this field.

The Final Meeting represents a crucial moment to meet each other, wrap up the main oblectives of the project and continue building up our community in order to keep addressing our common objective of improving the performance of plasma therapies for the benefit of the patients.

During the meeting, we will focus on the COST tasks of all our working groups, working together for the production of the specific final deliverables. Also, it is of  great importance to present the results of the STSMs performed in the last year among PlasTHER members.

Dr. Cristina Canal